Boston, Massachusetts hosts one the world’s renowned chemist and healthcare expert, Scott M. Rocklage. He entered the field over three decades ago exuding impressive leadership, organizational and management skills over the years. He is known for driving Omniscan, Cubicin and Teslascan drugs to attain the FDA approval. Other drug candidates have reached clinical trials thanks to his efforts. Scott Rocklage boasts more than 30 patents to his name and over 100 publications that he has authored and co-authored. His background training has been very instrumental in his career journey. He holds a Bachelor of Science degree in chemistry earned from the University of California in Berkeley. He also furthered his education in the area at the Massachusetts Institute of Technology where he earned his Ph.D. he used the laboratory of Richard R. Schrock who won the 2005 Nobel Prize in Chemistry for his research.
Scott Rocklage began his career in 1990 at Nycomed Salutor as the President and Chief Executive Officer. While still working there, he joined Nycomed Interventional Inc as the Chief Executive officer, President, and Chairman. He left the two posts in 1994 to join Cubist Pharmaceuticals Inc. He was the President of the firm until 2001 and Founding Chief Executive officer until 2003. He has also held leadership positions in Amersham Health, Ilypsa, and EPIRUS Biopharmaceuticals. He has worked in the Research and Developments departments at Catalytica and Salutar Pharmaceuticals. Scott has served on various boards including Relypsa, Inc., Cubist Pharmaceuticals Miikana Therapeutics Inc, and Pulmatrix, Inc. among others.
Scott Rocklage became a Venture Partner at 5 AM Ventures in 2003 and a Managing Partner the following year. The firm as the name depicts supports companies in the healthcare industry at the early stages of their formation. Scott helps these entrepreneurs in realizing their ideas by offering the much-needed capital and information to set up their businesses. He is very committed to ensuring that healthcare needs are solved with ease.
Besides his role here, Scott Rocklage currently serves on the board of directors for various companies. They include Novira Therapeutics, Cidara Therapeutics Inc., Rennovia Inc, Nouscom AG, and Whitehead Institute.
Connect with Scott Rocklage on LinkedIn.